| 718148 |
FRONTIERS IN ONCOLOGY |
Combination Treatment of CI-994 With Etoposide Potentiates Anticancer Effects Through a Topoisomerase II-Dependent Mechanism in Atypical Teratoid/Rhabdoid Tumor (AT/RT) |
2021-07-21 |
10.3389/fonc.2021.648023 |
Kim Hee Yeon, Choi Seung Ah, Koh Eun Jung, Kim Kyung Hyun, Phi Ji Hoon, Lee Ji Yeoun, Kim Seung-Ki |
| 718147 |
FRONTIERS IN ONCOLOGY |
Interactions Between Adiponectin-Pathway Polymorphisms and Obesity on Postmenopausal Breast Cancer Risk Among African American Women: The WHI SHARe Study |
2021-07-21 |
10.3389/fonc.2021.698198 |
Nam Gina E., Zhang Zuo-Feng, Rao Jianyu, Zhou Hua, Jung Su Yon |
| 718146 |
FRONTIERS IN ONCOLOGY |
Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers |
2021-07-21 |
10.3389/fonc.2021.625668 |
Daher Sameh, Lawrence Yaacov R., Dudnik Elizabeth, Hanovich Ekaterina, Urban Damien, Peled Nir, Navon Rossie, Leibowitz Raya, Hammerman Ariel, Battat Erez, Gottfried Teodor, Onn Amir, Bar Jair |
| 718145 |
FRONTIERS IN ONCOLOGY |
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma |
2021-07-21 |
10.3389/fonc.2021.703233 |
Lecat Catherine S. Y., Taube Jessica B., Wilson William, Carmichael Jonathan, Parrish Christopher, Wallis Gabriel, Kyriakou Charalampia, Lee Lydia, Mahmood Shameem, Papanikolaou Xenofon, Rabin Neil K., Sive Jonathan, Wechalekar Ashutosh D., Yong Kwee, Cook Gordon, Popat Rakesh |
| 718144 |
FRONTIERS IN ONCOLOGY |
The Provocative Roles of Platelets in Liver Disease and Cancer |
2021-07-21 |
10.3389/fonc.2021.643815 |
Kanikarla Marie Preeti, Fowlkes Natalie W., Afshar-Kharghan Vahid, Martch Stephanie L., Sorokin Alexey, Shen John Paul, Morris Van K., Dasari Arvind, You Nancy, Sood Anil K., Overman Michael J., Kopetz Scott, Menter David George |
| 718143 |
FRONTIERS IN ONCOLOGY |
Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients |
2021-07-21 |
10.3389/fonc.2021.664794 |
García-Trejo José J., Ortega Raquel, Zarco-Zavala Mariel |
| 718142 |
FRONTIERS IN ONCOLOGY |
Abiraterone In Vitro Is Superior to Enzalutamide in Response to Ionizing Radiation |
2021-07-21 |
10.3389/fonc.2021.700543 |
Wright Timothy C., Dunne Victoria L., Alshehri Ali H. D., Redmond Kelly M., Cole Aidan J., Prise Kevin M. |
| 718141 |
FRONTIERS IN ONCOLOGY |
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma |
2021-07-21 |
10.3389/fonc.2021.731942 |
Yao Yicong, Wang Yi, Wu Denglong, Hu Baoying |
| 718140 |
FRONTIERS IN ONCOLOGY |
Hyperbaric Oxygen Therapy Represses the Warburg Effect and Epithelial–Mesenchymal Transition in Hypoxic NSCLC Cells via the HIF-1α/PFKP Axis |
2021-07-21 |
10.3389/fonc.2021.691762 |
Zhang Linling, Ke Jingjing, Min Shengping, Wu Nan, Liu Fei, Qu Zhen, Li Wei, Wang Hongtao, Qian Zhongqing, Wang Xiaojing |
| 718139 |
FRONTIERS IN ONCOLOGY |
The Impact of lncRNAs and miRNAs on Apoptosis in Lung Cancer |
2021-07-21 |
10.3389/fonc.2021.714795 |
Ghafouri-Fard Soudeh, Aghabalazade Amin, Shoorei Hamed, Majidpoor Jamal, Taheri Mohammad, Mokhtari Majid |
